[1] |
Nalesso F, Ferrario M, Moissl U, et al. Body composition and heart rate variability to achieve dry weight and tolerance[J]. Contrib Nephrol, 2011(171): 181–186.
|
[2] |
杨晓云,徐春芳,王铁锚,等.冠心病患者窦性心率震荡与心率变异性和室性早搏关系的探讨[J].临床心电学杂志,2009,18(1): 17–19.
|
[3] |
Cygankiewicz I, Zareba W. Heart rate variability[J]. Handb Clin Neurol, 2013, 117: 379–393.
|
[4] |
Kowalczyk M, Turska-Kmiec A, Ziolkowska L, et al. Symptoms diagnosis and characteristic abnormalities in the coronary arteries in Kawasaki disease in children[J]. Med Wieku Rozwoj, 2010, 14(4): 344–349.
|
[5] |
Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association[J]. Circulation, 2004, 110(17): 2747–2771.
|
[6] |
Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition)[J]. Pediatr Int, 2005, 47(2): 232–234.
|
[7] |
中华医学会儿科学分会心血管学组,中华医学会儿科学分会免疫学组,《中华儿科杂志》编辑委员会.川崎病冠状动脉病变的临床处理建议[J].中华儿科杂志,2012, 50(10): 746–749.
|
[8] |
吴蓉洲,荣星,任跃,等.750例健康儿童心率变异性分析[J].中华心律失常杂志,2011,15(1):37–39.
|
[9] |
Doi M, Takeda T, Sakurai Y, et al. Altered immunoglobulin A and M levels associated with changes in BAFF and APRIL after administration of intravenous immunoglobulin to treat Kawasaki disease[J]. J Investig Allergol Clin Immunol, 2010, 20(5): 413–418.
|
[10] |
鲁炜慧,杜忠东.与川崎病相关的基因多态性研究进展[J].实用儿科临床杂志,2010, 25(1): 60–62.
|
[11] |
饶世俊,施陈刚,苏微微,等.冠心病合并脑梗死患者心率变异性及心律失常的研究[J].实用医学杂志,2011, 17(7): 1231–1233.
|
[12] |
王江峰,王伟.急性心肌梗死患者心率变异性分析[J].中国医药指南,2012,10(9):129–130.
|
[13] |
Thayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors[J]. Int J Cardiol, 2010, 141(2): 122–131.
|
[14] |
Xhyheri B, Manfrini O, Mazzolini M, et al. Heart rate variability today[J]. Prog Cardiovasc Dis, 2012, 55(3): 321–331.
|
[15] |
Lightner DJ, Krambeck AE, Jacobson DJ, et al. Nocturia is associated with an increased risk of coronary heart disease and death[J]. BJU Int, 2012, 110(6): 848–853.
|
[16] |
Kurtoglu E, Balta S, Karakus Y, et al. Frequency domain parameters of heart rate variability should also be quoted in normalised units[J]. Acta Anaesthesiol Scand, 2014, 58(3): 370–371.
|
[17] |
Flahr D. The effect of nonweight bearing exercise and protocol adherence on diabetic foot ulcer healing:a pilot study[J]. Ostomy Wound Manage, 2010,56(10): 40–50.
|
[18] |
Otterman NM, Van Schie CH, van der Schaaf M, et al. An exercise programme for patients with diabetic complications:a study on feasibility and preliminary effect iness[J]. Diabet Med, 2011, 28(2): 212–217.
|
[19] |
Omerbegovic M. Analysis of heart rate variability and clinical implications[J]. Med Arch, 2009, 63(2): 102–105.
|
[20] |
Matsubara T, Ichiyama T, Furufawa S. Immunobgical profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease[J]. Clin Exp Immuno J, 2005, 141(3): 381–387.
|
[21] |
冯卫文,林娜.川崎病早期诊断的研究进展[J]. 右江医学,2010, 38(4): 483–485.
|
[22] |
Rocchi A, Mazzoni M, Bertolozzi G, et al. Atypical onset and course in a child with fulminant myocarditis[J]. Minerva Pediatr, 2012, 64(4): 447.
|
[23] |
Guglin M, Nallamshetty L. Myocarditis:diagnosis and treatment[J]. Curr Treat Options Cardiovas Med, 2012, 14(6): 637.
|